Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru

Author： Lanata C.F.   Black R.E.   Flores J.   Lazo F.   Butron B.   Linares A.   Huapaya A.   Ventura G.   Gil A.   Kapikian A.Z.  

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.14, Iss.3, 1996-02, pp. : 237-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK

By Hoshino Y.   Jones R.W.   Chanock R.M.   Kapikian A.Z.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3576-3584

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants

By Johansen K.   Schroder U.   Svensson L.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 368-375

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

By Clements-Mann M.L.   Makhene M.K.   Mrukowicz J.   Wright P.F.   Hoshino Y.   Midthun K.   Sperber E.   Karron R.   Kapikian A.Z.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2715-2725

Elsevier

Access to resources Recommend Favorite

Simultaneous administration of oral rhesus-human reassortant tetravalent (RRV-TV) rotavirus vaccine and oral poliovirus vaccine (OPV) in Thai infants

By Migasena S.   Simasathien S.   Samakoses R.   Pitisuttitham P.   Sangaroon P.   van Steenis G.   Beuvery E.C.   Bugg H.   Bishop R.   Davidson B.L.   Vesikari T.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 168-174

Elsevier

Access to resources Recommend Favorite